Insiders · Profile

BIZZARI JEAN-PIERRE

Director at ADC Therapeutics · Director at HALOZYME THERAPEUTICS. Filing since 25 Aug 2021. CIK 0001630914

Company
Date
Role
Action
Shares
Amount
Of holding
17 Jun 2024
Director
Sold at will
6,995
$20.22K
8.1%
25 Aug 2021
Director
Sold, plan not stated
35,000
$1.44M
40.0%
2 decisions on file.